表紙
市場調查報告書

美國的臨床檢驗市場:檢驗的各類型 (腫瘤,臨床化學,微生物,特殊)、研究室的各類型 (醫院,診療所,獨立型)、疾病的各類型 (結核,流感,癌症,HIV/AIDS等)的未來預測 (到2022年)

US Clinical Laboratory Testing Market By Type of Test (Tumor, Clinical Chemistry, Microbiology, Esoteric), By Type of Lab (Hospital, Physician, Independent), & By Type of Diseases (Tuberculosis, Influenza, Cancer, HIV/AIDS etc.), Forecast to 2022

出版商 RNCOS E-Services Pvt. Ltd. 商品編碼 423697
出版日期 內容資訊 英文 65 Pages
訂單完成後即時交付
價格
美國的臨床檢驗市場:檢驗的各類型 (腫瘤,臨床化學,微生物,特殊)、研究室的各類型 (醫院,診療所,獨立型)、疾病的各類型 (結核,流感,癌症,HIV/AIDS等)的未來預測 (到2022年) US Clinical Laboratory Testing Market By Type of Test (Tumor, Clinical Chemistry, Microbiology, Esoteric), By Type of Lab (Hospital, Physician, Independent), & By Type of Diseases (Tuberculosis, Influenza, Cancer, HIV/AIDS etc.), Forecast to 2022
出版日期: 2020年03月01日內容資訊: 英文 65 Pages
簡介

所謂臨床檢驗室,是提供醫生和患者日常、專門性的診斷檢驗服務的全方位服務的參照檢驗室。美國的臨床檢驗的市場,由於人口的高齡化,及民間積極進入市場,意識等級的上升,新技術的登場等要素支撐,完成順利的市場成長。

本報告提供美國的臨床檢驗市場相關分析,主要的推動市場要素,及市場趨勢與今後的預測,檢驗的各類型、各檢驗設施、疾病的各種類的詳細趨勢,市場發展的方向性,主要企業簡介等調查。

目錄

第1章 分析師的見解

第2章 調查手法

第3章 美國的臨床檢驗市場未來展望

第4章 市場區隔:檢驗的各類型

  • 臨床化學檢驗
  • 人/腫瘤遺傳基因檢驗
  • 醫療用微生物/細胞檢驗
  • 特殊檢驗

第5章 市場區隔:各檢驗室

  • 醫院檢驗室
  • 診療所檢驗室
  • 獨立型檢驗室

第6章 患者數的統計資料

第7章 市場促進因素與趨勢

  • 高齡化的進展
  • 發病者數的增加
  • 早期疾病檢測設施
  • 員工的健康計劃
  • 醫療費的增加
  • 事業合作、事業整合
  • 對革新的著重

第8章 主要企業

  • Laboratory Corporation of America (LabCorp)
  • OPKO Health Inc.
  • Sonic Healthcare USA
  • Quest Diagnostics
  • Alere Inc.
  • Abbott Laboratories
  • Charles River Laboratories
  • Healthscope Ltd
  • Genzyme (Sanofi的子公司)
  • Qiagen

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

The US clinical laboratories are a full service reference laboratories performing routine and specialized diagnostic testing service for physicians and patients. US represents an attractive destination for healthcare services' market segments, especially clinical lab testing, which has evolved as a major source of decisive factor for healthcare professionals and that too despite garnering a low proportion of total medical spending. It is estimated that the market for clinical lab testing in the US is poised to witness healthy growth backed by factors such as aging population, active private sector participation, and rising awareness level. With the emergence of new technologies, the market is likely to register further to an optimum CAGR in future.

Currently, the market is dominated by clinical chemistry tests, followed by human & tumor genomics. The future, however, holds significant promise for human and tumor genomics testing. The future growth in this segment is driven by strong growth in personalized laboratory testing on tumor tissues and other key factors. The report, in this context, offers effective information and analysis on the market landscape for key tests type, with special emphasis on their future performance.

Moreover, the report provides the current and future market for different types of tests. The report also divides the market on the basis of types of labs into hospital based laboratories, physician laboratories, and independent laboratories. The physician laboratories accounted for the largest share in the US clinical laboratory testing market in 2016.

The US market for clinical laboratory diagnostics is highly fragmented, with large number of labs offering services in different states of the country. Some players, however, have leading edge in comparison to other companies. Quest diagnostics, LabCorp and Sonic Healthcare are the key independent laboratories that have augmented their reach in the market with proper focus on consolidation activities. Our report entitled "US Clinical Laboratory Testing Market By Type of Test (Tumor, Clinical Chemistry, Microbiology, Esoteric), By Type of Lab (Hospital, Physician, Independent), & By Type of Diseases (Tuberculosis, Influenza, Cancer, HIV/AIDS etc.), Forecast to 2022" provides an in-depth insight into the operations, services, financial performance of the key players in order to gauge their attractiveness in terms of investment and future participation in the market. Overall, the report is likely to be proved beneficial for all those entities who want to enter the market, or make decisions regarding investment.

TABLE OF CONTENTS

1. Analyst View

2. Research Methodology

3. US Clinical Laboratory Testing Market Outlook 2022

4. Market Segmentation by Test Type

  • 4.1 Clinical Chemistry Laboratory
  • 4.2 Human & Tumor Genetics Laboratory
  • 4.3 Medical Microbiology & Cytology Laboratory
  • 4.4 Esoteric Tests

5. Market Segmentation by Laboratories

  • 5.1 Hospital Laboratories
  • 5.2 Physician Laboratories
  • 5.3 Independent Laboratories

6. Disease Demographics

7. Drivers & Trends

  • 7.1 Growing Ageing Population
  • 7.2 Rising Disease Incidence
  • 7.3 Early Disease Detection Facilities
  • 7.4 Employer Wellness Programs
  • 7.5 Increased Health Care Spending
  • 7.6 Collaboration & Consolidation
  • 7.7 Focusing on Innovations

8. Key Players

  • 8.1 Laboratory Corporation of America (LabCorp)
  • 8.2 OPKO Health Inc.
  • 8.3 Sonic Healthcare USA
  • 8.4 Quest Diagnostics
  • 8.5 Alere Inc.
  • 8.6 Abbott Laboratories
  • 8.7 Charles River Laboratories
  • 8.8 Healthscope Ltd
  • 8.9 Genzyme (Subsidiary of Sanofi)
  • 8.10 Qiagen

List of Figures

  • Figure 3-1: US - Clinical Laboratory Testing Market (Billion US$), 2016 & 2022
  • Figure 4-1: US - Clinical Laboratory Testing Market by Test Type (%), 2016
  • Figure 4-2: US - Clinical Chemistry Laboratory Testing Market (Billion US$), 2016 & 2022
  • Figure 4-3: US - Human & Tumor Genetics Laboratory Testing Market (Billion US$), 2016 & 2022
  • Figure 4-4: US - Medical Microbiology & Cytology Laboratory Testing Market (Billion US$), 2016 & 2022
  • Figure 4-5: US - Esoteric Laboratory Testing Market (Billion US$), 2016 & 2022
  • Figure 5-1: US - Clinical laboratory Testing Market Segment by Laboratories (%), 2016
  • Figure 5-2: US - Hospital Laboratory Testing Market (Billion US$), 2016 & 2022
  • Figure 5-3: US - Physician Laboratory Testing Market (Billion US$), 2016 & 2022
  • Figure 5-4: US - Independent Laboratory Testing Market (Billion US$), 2016 & 2022
  • Figure 7-1: US - Population 65 Years and Above (Million), 2016 & 2060
  • Figure 7-2: US - Prevalence of Cancer (Million), 2014 & 2024.
  • Figure 7-3: US - Number of Closed M&A Deals in Lab Industry (2001-2013)
  • Figure 8-1: LabCorp - Net Revenue by Segment (%), 2015
  • Figure 8-2: LabCorp - Net Revenue by Geography (%), 2015
  • Figure 8-3: OPKO Health Inc. - Revenue by Geography (%), 2015
  • Figure 8-4: Sonic Healthcare - Revenue by Segment (%), 2016
  • Figure 8-5: Sonic Health - Revenue by Geography (%), 2016
  • Figure 8-6: Alere Inc. - Revenue by Segment (%), 2015
  • Figure 8-7: Alere Inc. - Revenue by Geography (%), 2015
  • Figure 8-8: Abbott - Net Sales by Segment (%), 2015
  • Figure 8-9: Abbott - Net Sales by Geography (%), 2015
  • Figure 8-10: Charles River Laboratories - Revenue by Segment (%), 2015
  • Figure 8-11: Charles River Laboratories - Revenue by Geography (%), 2015
  • Figure 8-12: Healthscope Ltd. - Revenue by Segment (%), 2016
  • Figure 8-13: Sanofi - Net Sales by Geography (%), 2015
  • Figure 8-14: Qiagen - Net Sales by Segment (%), 2015
  • Figure 8-15: Qiagen - Net Sales by Geography (%), 2015

List of Tables

  • Table 6-1: US - Tuberculosis Incidences (2014 & 2015)
  • Table 6-2: US - Influenza Incidences (2013 & 2014)
  • Table 6-3: US - HIV/AIDS Incidences (2013 & 2014)
  • Table 6-4: US - Gonorrhea Incidences (2013, 2014 & 2015)
  • Table 6-5: US - Cirrhosis Incidences (2013 & 2014)
  • Table 6-6: US - Kidney Diseases Incidences (2013 & 2014)
  • Table 6-7: US - Cancer Incidences (2013, 2014 & 2015)
  • Table 8-1: LabCorp - Financials (Million US$), 2013, 2014 & 2015
  • Table 8-2: OPKO - Financials (Million US$), 2013, 2014 & 2015
  • Table 8-3: Sonic Healthcare - Financials, (Million US$), 2014, 2015 & 2016
  • Table 8-4: Quest Diagnostics - Financials, (Million US$), 2013, 2014 & 2015
  • Table 8-5: Alere Inc. - Financials (Million US$), 2013, 2014 & 2015
  • Table 8-6: Abbott - Financials (Million US$), 2013, 2014 & 2015
  • Table 8-7: Charles River Laboratories - Financials (Million US$), 2013, 2014 & 2015
  • Table 8-8: Healthscope Ltd. - Financials (Million US$), 2014, 2015 & 2016
  • Table 8-9: Sanofi - Financials (Million US$), 2013, 2014 & 2015
  • Table 8-10: Qiagen - Financials (Million US$), 2013, 2014 & 2015